Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age55+
SponsorPopulation Health Research Institute

About this trial

Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.

Eligibility criteria

Qualifiers

noncardiac surgery in the past 35 days, with at least an overnight hospital admission aftersurgery;

noncardiac day surgery resulting in a large enough physiological insult to be able to cause AFOTS, as judged by the local investigator; or

acute medical illness requiring hospital admission in the past 35 days and resulting in a large enough physiological insult to be able to cause AFOTS, as judged by the local investigator;

sinus rhythm at the time of randomization;

Disqualifiers

any cardiac diagnosis as the primary reason for hospital admission;

history of documented chronic AF prior to noncardiac surgery;

need for long-term systemic anticoagulation;

ongoing need for long-term dual antiplatelet treatment;

Trial design

Treatments tested in this trial

  • Non-vitamin K oral anticoagulant (NOAC)

Treatment groups

2,270 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Population Health Research Institute

Lead sponsor

Hamilton Health Sciences Corporation

Collaborator